| HRQOL Questionnaire items |
HRQOL items scores [median (IQR)] |
| Adherence |
Drug side effects |
Self-medication |
| Yes (n=205) |
No (n=26) |
p |
No (n=183) |
Yes (n=48) |
p |
No (n=97) |
Yes (n=134) |
p |
| Global HRQOL score |
80.98
(73.76-87.22) |
75.44
(70.11-81.89) |
0.01 |
81.27
(73.76-87.36) |
78.23
(72.04-82.62) |
0.03 |
81.11
(74.42-87.97) |
80.12
(71.64-85.91) |
0.08 |
| GHP |
60
(50-70) |
55
(45-65) |
0.04 |
60
(50-70) |
60
(50-70) |
0.69 |
60
(50-70) |
60
(50-70) |
0.88 |
| PF |
100
(91.66-100) |
91.66
(66.66-100) |
0.05 |
100
(91.66-100) |
91.66
(83.33-100) |
0.01 |
100
(91.66-100) |
100
(91.66-100) |
0.07 |
| RF |
100
(100-100) |
100
(100-100) |
0.68 |
100
(100-100) |
100
(100-100) |
0.55 |
100
(100-100) |
100
(100-100) |
0.31 |
| P |
77.77
(55.55-100) |
66.66
(44.44-100) |
0.14 |
88.88
(55.55-100) |
66.66
(55.55-100) |
0.24 |
100
(55.55-100) |
66.66
(55.55-100) |
0.10 |
| SF |
100
(100-100) |
100
(100-100) |
0.26 |
100
(100-100) |
100
(100-100) |
0.44 |
100
(100-100) |
100
(100-100) |
0.34 |
| MH |
68
(56-80) |
68
(52-76) |
0.77 |
68
(56-80) |
64
(52-78) |
0.20 |
72
(56-80) |
68
(56-76) |
0.04 |
| EF |
85
(70-90) |
80
(65-90) |
0.32 |
85
(70-95) |
77.50
(62.5-90) |
0.05 |
85
(70-95) |
80
(70-90) |
0.03 |
| HD |
95
(80-100) |
92.5
(65-100) |
0.38 |
95
(80-100) |
92.5
(72.5-100) |
0.49 |
100
(80-100) |
95
(75-100) |
0.13 |
| CF |
90
(80-100) |
85
(75-100) |
0.22 |
95
(80-100) |
87.5
(70-100) |
0.03 |
95
(85-100) |
85
(75-100) |
0.007 |
| QL |
75
(50-100) |
50
(50-75) |
0.04 |
75
(50-100) |
75
(50-100) |
0.34 |
75
(50-100) |
75
(50-100) |
0.43 |
| HT |
75
(50-75) |
50
(50-75) |
0.15 |
75
(50-75) |
75
(50-75) |
0.96 |
75
(50-75) |
75
(50-75) |
0.76 |
p: Mann-Whitney test, IQR: interquartile range; GHP: General Health Perceptions, PF: Physical Functioning, RF: Role Functioning, P: Pain, SF: Social Functioning, MH:
Mental Health, EF: Energy/Fatigue, HD: Health Distress, CF: Cognitive Functioning, QL: Quality of Life, HT: Health Transition. |
